Compare · OPCH vs VSEE
OPCH vs VSEE
Side-by-side comparison of Option Care Health Inc. (OPCH) and VSee Health Inc. (VSEE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and VSEE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.22B, about 416.8x VSEE ($7.7M).
- Over the past year, OPCH is down 35.3% and VSEE is down 86.0% - OPCH leads by 50.6 points.
- OPCH has been more active in the news (12 items in the past 4 weeks vs 3 for VSEE).
- OPCH has more recent analyst coverage (14 ratings vs 1 for VSEE).
- Company
- Option Care Health Inc.
- VSee Health Inc.
- Price
- $20.48+2.02%
- $0.16-6.98%
- Market cap
- $3.22B
- $7.7M
- 1M return
- +0.17%
- -13.15%
- 1Y return
- -35.33%
- -85.95%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 12
- 3
- Recent ratings
- 14
- 1
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest OPCH
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)
Latest VSEE
- VSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update
- Co-Chief Executive Officer Chen Milton disposed of 2,870,069 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 424B3 filed by VSee Health Inc.
- SEC Form 10-Q filed by VSee Health Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by VSee Health Inc.
- SEC Form POS EX filed by VSee Health Inc.
- SEC Form 424B3 filed by VSee Health Inc.
- VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
- SEC Form 10-K filed by VSee Health Inc.
- SEC Form 4 filed by Leonard Jerry